Nicolet Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Nicolet Advisory Services's PFE Position: Q4 2025 in Review
Nicolet Advisory Services increased its Pfizer (PFE) stake by 15% in Q4 2025, buying an estimated $166K and bringing the position to 49,120 shares worth $1.24M. The position accounts for 0.08% of the portfolio, ranked #118.
Nicolet Advisory Services first reported a position in PFE in Q1 2019 and has held it in 28 quarters since. The position peaked at $1.47M in Q1 2023. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Nicolet Advisory Services held 49,120 shares of Pfizer worth $1.24M as of Q4 2025.
- Nicolet Advisory Services bought 6,583 Pfizer shares in Q4 2025, an estimated $166K.
- Pfizer made up 0.08% of Nicolet Advisory Services's portfolio in Q4 2025, its #118 holding.
- Nicolet Advisory Services first reported a position in Pfizer in Q1 2019 and has held it in 28 quarters since.
- Nicolet Advisory Services's Pfizer position peaked at $1.47M in Q1 2023.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Nicolet Advisory Services's 13F filing for Q4 2025, filed 13 Feb 2026.